IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Net income 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$391.0MFY2025 · since FY2016: -$52.9M → -$391.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$391.0M | -5.1% |
| FY2024 | -$372.2M | +16.2% |
| FY2023 | -$444.0M | -12.1% |
| FY2022 | -$395.9M | -15.7% |
| FY2021 | -$342.3M | -31.9% |
| FY2020 | -$259.6M | -31.4% |
| FY2019 | -$197.6M | -59.9% |
| FY2018 | -$123.6M | -34.2% |
| FY2017 | -$92.1M | -74.1% |
| FY2016 | -$52.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice